Tentt

Kailera Therapeutics Plans IPO for Obesity Drug

Announced
HealthcareOther

Deal Overview

Kailera Therapeutics plans an IPO focused on an obesity drug candidate intended to compete in the Zepbound category. The company’s public-market plans center on bringing its obesity-treatment program forward through a listing.

No pricing, proceeds, or terms are included in the provided material.

Key Details

Target
Kailera Therapeutics

Filed under

Source

Read full article on medcitynews.com

via MedCity News · March 30, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →